384 First in Human Use of a Novel in Vivo Gene Therapy to Successfully Correct Recessive Dystrophic Epidermolysis Bullosa (RDEB) Skin: Results of a Phase 1/2 Placebo Controlled Trial
Journal of Investigative Dermatology - United Kingdom
doi 10.1016/j.jid.2019.03.460
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2019
Authors
Publisher
Elsevier BV